Skip to main content
. Author manuscript; available in PMC: 2023 Jul 4.
Published in final edited form as: Lancet Haematol. 2023 Jan 25;10(3):e225–e234. doi: 10.1016/S2352-3026(22)00353-2

Table 2.

Approaches to address fertility care for haemoglobinopathy trait carriers and people with sickle cell disease in the USA require coordinated actions by institutions and organisations

Actions to address, clinical care, research and access gaps
Screening for hemoglobinopathy traits CDC, USPTF, ACOG, ASH, AAP Universal pre-conception genetic counseling
Opportunity for hemoglobinopathy testing
Clinical Care NHLBI/NIH, ASH, ACOG, ASRM, AAP, ASPHO, SMFM, NASCC Comprehensive reproductive care guidelines
Systematic approach to fertility and preconception counseling, evaluations, referrals
Research CDC ART Surveillance & Research Team, SART Create ART Surveillance Systems to identify SCD-related use & define outcomes for IVF+PGT in couples without infertility diagnosis
NIH (NHLBI, NICHD, ORWH), ASH, ASRM, AUA Create RFAs for high-quality clinical fertility research in SCD
Policy Changes CMS, HRSA, State and Federal Lawmakers Fund comprehensive SCD care
Fund or mandate coverage for patients anticipating iatrogenic infertility
Comprehensive, non-coercive genetic counseling and ART coverage for people with SCD and hemoglobin carrier couples

ACOG: American College of Obstetrics and Gynecology, ASH: American Society of Hematology, ASPHO: American Society of Pediatric Hematology & Oncology, ASRM: American Society of Reproductive Medicine, ART: Artificial Reproductive Technology, AUA: American Urological Association, CDC: Centers for Disease Control and Prevention, CMS: Centers for Medicaid and Medicare, HRSA: Health Resources and Services Administration, IVF++PGT: In Vitro Fertilization + Preimplantation Genetic Testing, NICHD: National Institute of Child Health and Human Development, NIH: National Institutes of Health, NHLBI: National Heart, Lung and Blood Institute, ORWH: Office for Research in Women’s Health, NASCC=National Alliance for Sickle Cell Centers, RFA: Research Funding Announcement; SART: Society for Assisted Reproductive Technologies, SMFM, Society for Maternal and Fetal Medicine, USPTF: United States Preventive Task Force